Document Classification

Section Type: RESULTS

Text: Compared with the placebo group, the 20 mg of rimonabant group produced greater mean (SEM) reductions in weight (-6. 3 [0. 2] kg vs -1. 6 [0. 2] kg ; P <. 001), waist circumference (-6. 1 [0. 2] cm vs -2. 5 [0. 3] cm ; P <. 001), and level of triglycerides (percentage change, -5. 3 [1. 2] vs 7. 9 [2. 0] ; P <. 001) and a greater increase in level of high-density lipoprotein cholesterol (percentage change, 12. 6 [0. 5] vs 5. 4 [0. 7] ; P <. 001).